Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers

Published:2018-04-23 Issue:8 Volume:20 Page:1988-1993
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Dekkers Claire C. J.¹^ORCID,Petrykiv Sergei²,Laverman Gozewijn D.³,Cherney David Z.⁴⁵,Gansevoort Ron T.¹,Heerspink Hiddo J. L.¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology; University of Groningen, University Medical Center Groningen; Groningen The Netherlands

2. Department of Nephrology; University of Groningen, University Medical Center Groningen; Groningen The Netherlands

3. Department of Nephrology, Ziekenhuisgroep Twente, Almelo and Hengelo; The Netherlands

4. Department of Medicine, Division of Nephrology; Toronto General Hospital, University of Toronto; Toronto Canada

5. Department of Physiology and Banting and Best Diabetes Centre; University of Toronto; Toronto Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13301/fullpdf

Reference22 articles.

1. Canagliflozin slows progression of renal function decline independently of glycemic effects;Heerspink;J Am Soc Nephrol,2017

2. Empagliflozin and progression of kidney disease in type 2 diabetes;Wanner;N Engl J Med,2016

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

4. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus;Cherney;Circulation,2014

5. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications;Heerspink;Circulation,2016

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sodium glucose Co-transporter 2 inhibitor use on anthropometric measurements and blood glucose in obese and non-obese type 2 diabetic patients;Clinical Nutrition ESPEN;2024-10

2. The Impact of Empagliflozin on Renal Function and Kidney Injury Markers in Patients with Diabetic Nephropathy;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-09-14

3. Effect of SGLT-2 inhibitors on acute kidney injury in patients with heart failure: a systematic review and meta-analysis;Diabetology & Metabolic Syndrome;2024-08-27

4. Role of NHERF1 in MicroRNA Landscape Changes in Aging Mouse Kidneys;Biomolecules;2024-08-23

5. Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography;Clinical Kidney Journal;2024-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3